Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ1,03
KB-1,03
PKN65,965,91-4,46
Msft0,23
Nokia3,1683,197-0,03
IBM1,38
Mercedes-Benz Group AG74,474,42-2,14
PFE-0,85
16.04.2024 23:15:38
Indexy online
AD Index online
select
AD Index online
 

  • 16.04.2024 17:33:49
Tecan Group (TECN.S, Swiss Exchange)
Poslední obchod Změna (%) Změna (CHF) Objem obchodů (CHF)
337,20 -2,54 -8,80 9 664 363
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.04.2024
Popis společnosti
Obecné informace
Název společnostiTecan Group AG
TickerTECN
Kmenové akcie:Ordinary Shares
RICTECN.S
ISINCH0012100191
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 3 591
Akcie v oběhu k 04.04.2024 12 807 765
MěnaCHF
Kontaktní informace
UliceSeestrasse 103
MěstoMAENNEDORF
PSČ8708
ZeměSwitzerland
Kontatní osoba 
Funkce kontaktní osoby 
Telefon41 449 228 111
Fax41449228112

Business Summary: Tecan Group AG is a Switzerland-based company engaged in the development, production and distribution of advanced automation and detection solutions for the life science laboratories. Its product portfolio is diversified into several product groups. The Liquid Handling & Robotics group encompasses laboratory technologies for safety, among others. The Reader & Washer product group covers micro plate instruments. The Microarray Products group includes microarray scanner and automated hybridization station. The HP D300 Digital Dispenser and Sample Management product groups cover systems for automated management of sample libraries. The Components group covers the supply services of products for laboratory automation instruments. The OEM (original equipment manufacturing) product group covers platform-based systems, systems from scratch and Cavro OEM Components. The Company also offers packaged software and consumables through Software and Consumables product groups, respectively.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Tecan Group AG revenues decreased 6% to SF1.07B. Net income increased 9% to SF132.1M. Revenues reflect Life Sciences Business segment decrease of 8% to SF451.8M, Partnering Business segment decrease of 5% to SF622.6M, Europe (excluding Switzerland) segment decrease of 23% to SF293.6M, Asia segment decrease of 8% to SF158M, Others segment decrease of 25% to SF11.9M.
Odvětvová klasifikace
TRBC2009Office Equipment
TRBC2012Scientific & Precision Equipment
RBSS2004Biotechnology
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICAnalytical Instruments
SICSurgical And Medical Instruments
SICCommercial Physical Research



  • Poslední aktualizace: 16.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Member of the Management BoardAchim von Leoprechting5601.04.2019
Chief Financial Officer, Member of the Management BoardTania Micki5317.02.202017.02.2020
Chief People Officer, Member of the Management BoardIngrid Purgstaller44
Executive Vice President, Chief Technology Officer, Head Research and Development, Member of the Management BoardWael Yared6201.01.2019
Executive Vice President, General Counsel and Secretary of the Board of Directors, Member of the Management BoardAndreas Wilhelm5501.01.2004
Executive Vice President, Head of the Partnering Business division, Member of the Management BoardRalf Griebel52
Executive Vice President, Global Head of Operations & IT, Member of the Management BoardUlrich Kanter61
Executive Vice President, Head of the Life Sciences Business Division, Member of the Management BoardKlaus Lun52
Executive Vice President, Head of Corporate Development, Member of the Management BoardErik Norstrom50